Wladimir Hogenhuis
2018
In 2018, Wladimir Hogenhuis earned a total compensation of $5.3M as Chief Operating Officer and Executive Vice President at Ultragenyx Pharmaceutical.
Compensation breakdown
| Bonus | $200,000 |
|---|---|
| Non-Equity Incentive Plan | $67,021 |
| Option Awards | $3,504,533 |
| Salary | $110,923 |
| Stock Awards | $1,159,500 |
| Other | $215,827 |
| Total | $5,257,804 |
Hogenhuis received $3.5M in option awards, accounting for 67% of the total pay in 2018.
Hogenhuis also received $200K in bonus, $67K in non-equity incentive plan, $110.9K in salary, $1.2M in stock awards and $215.8K in other compensation.
Rankings
In 2018, Wladimir Hogenhuis' compensation ranked 1,884th out of 14,244 executives tracked by ExecPay. In other words, Hogenhuis earned more than 86.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,884 out of 14,244 | 87th |
Division Manufacturing | 675 out of 5,759 | 88th |
Major group Chemicals And Allied Products | 221 out of 2,122 | 90th |
Industry group Drugs | 174 out of 1,811 | 90th |
Industry Pharmaceutical Preparations | 132 out of 1,385 | 91st |
Source: SEC filing on April 22, 2019.
Hogenhuis' colleagues
We found six more compensation records of executives who worked with Wladimir Hogenhuis at Ultragenyx Pharmaceutical in 2018.
2018
Camille Bedrosian
Ultragenyx Pharmaceutical
Chief Medical Officer
2018
Emil Kakkis
Ultragenyx Pharmaceutical
Chief Executive Officer
2018
Shalini Sharp
Ultragenyx Pharmaceutical
Chief Financial Officer
2018
Karah Parschauer
Ultragenyx Pharmaceutical
General Counsel
2018
Thomas Kassberg
Ultragenyx Pharmaceutical
Chief Business Officer and Executive Vice President
2018
John Pinion
Ultragenyx Pharmaceutical